Singh_2011_Eur.J.Pharmacol_652_157

Reference

Title : RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes - Singh_2011_Eur.J.Pharmacol_652_157
Author(s) : Singh S , Roy S , Sethi S , Benjamin B , Sundaram S , Khanna V , Kandalkar SR , Pal C , Kant R , Patra AK , Rayasam G , Mittra S , Saini KS , Paliwal J , Chugh A , Ahmed S , Sattigeri J , Cliff I , Ray A , Bansal VS , Bhatnagar PK , Davis JA
Ref : European Journal of Pharmacology , 652 :157 , 2011
Abstract : Singh_2011_Eur.J.Pharmacol_652_157
ESTHER : Singh_2011_Eur.J.Pharmacol_652_157
PubMedSearch : Singh_2011_Eur.J.Pharmacol_652_157
PubMedID: 20540938

Related information

Citations formats

Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA (2011)
RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes
European Journal of Pharmacology 652 :157

Singh S, Roy S, Sethi S, Benjamin B, Sundaram S, Khanna V, Kandalkar SR, Pal C, Kant R, Patra AK, Rayasam G, Mittra S, Saini KS, Paliwal J, Chugh A, Ahmed S, Sattigeri J, Cliff I, Ray A, Bansal VS, Bhatnagar PK, Davis JA (2011)
European Journal of Pharmacology 652 :157